Tumour vascular disrupting agents: combating treatment resistance.

@article{Tozer2008TumourVD,
  title={Tumour vascular disrupting agents: combating treatment resistance.},
  author={Gillian M. Tozer and Chryso Kanthou and Gillan Lewis and Vivien E Prise and Boris Vojnovic and Sally A. Hill},
  journal={The British journal of radiology},
  year={2008},
  volume={81 Spec No 1},
  pages={S12-20}
}
A large group of tubulin-binding microtubule-depolymerizing agents act as tumour vascular disrupting agents (VDAs). Several members of this group are now in clinical trials in combination with conventional anticancer drugs and radiotherapy. Here we briefly update on the development of tubulin-binding combretastatins as VDAs, summarize what is known of their mechanisms of action and address issues relating to treatment resistance, using disodium combretastatin A-4 3-O-phosphate (CA-4-P) as an… CONTINUE READING
25 Citations
72 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 25 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 72 references

Similar Papers

Loading similar papers…